PSA (Prostate)

The PSA (prostate) test is an important tool for diagnosing and monitoring prostate conditions, including prostate cancer. If you have any questions or concerns about the test, it’s always best to consult with your doctor. Visit the IntroLab website to schedule your PSA test and learn more about this and other diagnostic options.

What is a PSA (prostate) test?

The PSA test, which stands for Prostate-Specific Antigen, is used for diagnosing, monitoring, and managing various prostate conditions. The prostate is a small gland in men that produces seminal fluid, which nourishes and transports sperm. PSA is a protein produced by the prostate.

Normal PSA levels vary based on several factors, including age and prostate size. Doctors use the results of the PSA test, along with other information, to assess the risk of prostate cancer. This test is also sometimes used to monitor patients already diagnosed with prostate cancer, to check the effectiveness of treatment or detect any recurrence of the disease.

Elevated PSA levels

There are several situations where PSA levels may be elevated:

• Benign Prostatic Hyperplasia (BPH): An enlargement of the prostate, commonly seen in older men, can cause an increase in PSA levels. BPH is a non-cancerous condition and not related to prostate cancer.
• Prostatitis: Inflammation of the prostate can temporarily raise PSA levels. Prostatitis may result from an infection or other factors.
• Prostate Cancer: Prostate cancer can elevate PSA levels. However, it is important to note that elevated PSA does not necessarily mean prostate cancer, as other prostate conditions can also cause an increase.
• Age: It is normal for PSA levels to rise gradually with age. Older men may have slightly higher PSA levels, even within the normal range.

When is a PSA test necessary?

PSA testing is recommended based on the following guidelines:

• Routine Screening: A PSA test is advised for healthy men without a family history of prostate cancer starting at age 50. This helps in the early detection of potential prostate issues.
• Preventive Testing: Men with a family history of prostate cancer should begin PSA testing at age 40. This is important for early detection of possible prostate problems.
• Evaluation and Monitoring: For individuals already diagnosed with prostate cancer or other prostate conditions, doctors will recommend PSA testing based on their specific health situation. This helps assess the progression of the disease and monitor the effectiveness of treatment.

Consulting with a doctor is the best way to determine when to begin PSA testing.

Understanding the results

PSA test results are typically measured as the amount of PSA in a unit of blood (ng/mL). A higher PSA level may suggest an issue with the prostate, but it doesn’t always indicate cancer. Other conditions, such as prostate inflammation or infection, can also cause elevated levels. Your doctor will help interpret the test results and determine the appropriate next steps.

Determining tumor markers: Methods and timing

Tumor markers are substances that are often found in higher concentrations in individuals with certain types of cancer. These markers can be proteins, biochemical substances, or cellular changes detectable in blood, urine, or tissue samples. In oncology, tumor markers are commonly used to monitor treatment effectiveness, detect cancer recurrence, and, in some cases, for early cancer detection.

Tumor marker tests can be used in various situations:

• Diagnosis
• Disease staging
• Monitoring treatment
• Detecting recurrence

The timing and frequency of tumor marker testing vary depending on the type of cancer, the treatment, and the patient’s condition. The decision about when to test for tumor markers is best made in consultation with a doctor or oncologist.

Tumor marker tests are not perfect. Some cancer patients may not have elevated levels of certain tumor markers, and elevated levels can also result from conditions unrelated to cancer. Therefore, tumor markers are used as part of a comprehensive cancer diagnosis and monitoring strategy, rather than as the sole diagnostic tool.